
GC30466
CDK8-IN-3
Also known as N-(2-methoxyethyl)-3-[[4-(1-methylpyrazol-4-yl)phenyl]methyl]-2H-indazole-5-carboxamide
CDK8-IN-3 is an inhibitor of CDK8 extracted from patent WO2016041618A1, compound example 1·7
ChemicalCAS1884500-15-5MW389.45FormulaC22H23N5O2
- CAS number
- 1884500-15-5
- Molecular weight
- 389.45
- Formula
- C22H23N5O2
- Solubility
- DMSO : 50 mg/mL (128·39 mM; Need ultrasonic)
- InChIKey
- MYODQBLYOKTZML-UHFFFAOYSA-N
- Catalogue number
- GC30466
- Brand
- GLPBIO
Computed properties PubChem CID 118959920 · XLogP 2.6 · TPSA 84.8 Ų · H-bond donors 2
- XLogP
- 2.6
- TPSA
- 84.8 Ų
- H-bond donors
- 2
- H-bond acceptors
- 4
- Rotatable bonds
- 7
- Heavy atoms
- 29
SMILES CN1C=C(C=N1)C2=CC=C(C=C2)CC3=C4C=C(C=CC4=NN3)C(=O)NCCOC
Computed descriptors from PubChem (CID 118959920), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il